VPCCX quote
11.78up +0.14 +1.20%
Previous Close11.64CategoryLarge Growth
Net Assets4.26 BilDividend Yield1.05%
Morningstar ratings:Minimum Initial Purchase10,000
RiskBelow Average1 Year ReturnNA
RatingRating: 4 out of 53 Year ReturnNA
ReturnAbove Average5 Year ReturnNA
Cumulative growth of a $10,000 investment
10k growth chart
2005200620072008YTD
Growth12.07%25.87%34.73%-7.48%18.58%
Value$11,207$12,587$13,473$9,252$11,858
Last NAV update 11/23/2009 8:00 PM ET   Financial data in U.S. dollars

Your latest quotes:  FDGRX, VPCCX, CVS, OMX, OBCHX, TC2Y

Overview
The investment seeks to provide long-term capital appreciation. The fund currently invests in stocks of companies whose future earnings potential is not considered to be reflected in their current market prices. Its portfolio can consist of stocks across the capitalization spectrum. Up to 20% of total assets may be invested in foreign securities. The fund may also invest, to a limited extent, in derivatives.
More information for VPCCX
Fees and expenses
Front load0.00%
Deferred load0.00%
Expense Ratio0.50%
Top holdings for VPCCX
Company Name% Net Assets
CMT Market Liquidity Rate6.90%
Amgen, Inc.4.11%
Eli Lilly & Company3.12%
Novartis AG ADR2.81%
Roche Holding AG2.79%
More top holdings for VPCCX
Additional Fund Information
Inception date12/09/2004
ManagerDavid Van Slooten
Manager start date12/09/2004


Page generated 12:46 PM Eastern Time